nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA4—Alzheimer's disease	0.301	0.686	CbGaD
Celecoxib—CYP2D6—Alzheimer's disease	0.0746	0.17	CbGaD
Celecoxib—PTGS2—Alzheimer's disease	0.0627	0.143	CbGaD
Celecoxib—CYP2D6—Rivastigmine—Alzheimer's disease	0.0449	0.215	CbGbCtD
Celecoxib—CYP2C9—Donepezil—Alzheimer's disease	0.0393	0.188	CbGbCtD
Celecoxib—CYP2D6—Donepezil—Alzheimer's disease	0.0359	0.172	CbGbCtD
Celecoxib—CYP3A4—Rivastigmine—Alzheimer's disease	0.0286	0.136	CbGbCtD
Celecoxib—CYP2D6—Galantamine—Alzheimer's disease	0.0231	0.111	CbGbCtD
Celecoxib—CYP3A4—Donepezil—Alzheimer's disease	0.0228	0.109	CbGbCtD
Celecoxib—CYP3A4—Galantamine—Alzheimer's disease	0.0147	0.0703	CbGbCtD
Celecoxib—PDPK1—embryo—Alzheimer's disease	0.00269	0.0712	CbGeAlD
Celecoxib—MAPK14—blood vessel—Alzheimer's disease	0.00241	0.0638	CbGeAlD
Celecoxib—PDPK1—forebrain—Alzheimer's disease	0.00238	0.0629	CbGeAlD
Celecoxib—MAPK14—embryo—Alzheimer's disease	0.00144	0.0381	CbGeAlD
Celecoxib—PDPK1—nervous system—Alzheimer's disease	0.00129	0.0342	CbGeAlD
Celecoxib—MAPK14—forebrain—Alzheimer's disease	0.00127	0.0337	CbGeAlD
Celecoxib—PDPK1—central nervous system—Alzheimer's disease	0.00124	0.0329	CbGeAlD
Celecoxib—PDPK1—cerebellum—Alzheimer's disease	0.00122	0.0322	CbGeAlD
Celecoxib—MAPK14—telencephalon—Alzheimer's disease	0.00117	0.031	CbGeAlD
Celecoxib—CA14—telencephalon—Alzheimer's disease	0.00114	0.0301	CbGeAlD
Celecoxib—PDPK1—brain—Alzheimer's disease	0.000988	0.0261	CbGeAlD
Celecoxib—CA12—forebrain—Alzheimer's disease	0.000966	0.0255	CbGeAlD
Celecoxib—CA12—telencephalon—Alzheimer's disease	0.000888	0.0235	CbGeAlD
Celecoxib—PTGS2—blood vessel—Alzheimer's disease	0.000694	0.0183	CbGeAlD
Celecoxib—MAPK14—nervous system—Alzheimer's disease	0.000691	0.0183	CbGeAlD
Celecoxib—Etoricoxib—CYP2D6—Alzheimer's disease	0.00069	0.414	CrCbGaD
Celecoxib—CA9—cerebellum—Alzheimer's disease	0.000667	0.0176	CbGeAlD
Celecoxib—MAPK14—central nervous system—Alzheimer's disease	0.000665	0.0176	CbGeAlD
Celecoxib—ABCC4—forebrain—Alzheimer's disease	0.000651	0.0172	CbGeAlD
Celecoxib—MAPK14—cerebellum—Alzheimer's disease	0.00065	0.0172	CbGeAlD
Celecoxib—CA14—cerebellum—Alzheimer's disease	0.000633	0.0167	CbGeAlD
Celecoxib—CA4—forebrain—Alzheimer's disease	0.000598	0.0158	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—Alzheimer's disease	0.000579	0.347	CrCbGaD
Celecoxib—CA2—embryo—Alzheimer's disease	0.000561	0.0148	CbGeAlD
Celecoxib—CA4—telencephalon—Alzheimer's disease	0.00055	0.0145	CbGeAlD
Celecoxib—MAPK14—brain—Alzheimer's disease	0.000528	0.014	CbGeAlD
Celecoxib—CA12—nervous system—Alzheimer's disease	0.000524	0.0139	CbGeAlD
Celecoxib—CA14—brain—Alzheimer's disease	0.000514	0.0136	CbGeAlD
Celecoxib—CA12—central nervous system—Alzheimer's disease	0.000505	0.0133	CbGeAlD
Celecoxib—CA2—forebrain—Alzheimer's disease	0.000496	0.0131	CbGeAlD
Celecoxib—CA5B—nervous system—Alzheimer's disease	0.00047	0.0124	CbGeAlD
Celecoxib—CA2—telencephalon—Alzheimer's disease	0.000456	0.0121	CbGeAlD
Celecoxib—CA5B—central nervous system—Alzheimer's disease	0.000453	0.012	CbGeAlD
Celecoxib—ORM1—nervous system—Alzheimer's disease	0.000416	0.011	CbGeAlD
Celecoxib—PTGS2—embryo—Alzheimer's disease	0.000414	0.0109	CbGeAlD
Celecoxib—CA12—brain—Alzheimer's disease	0.000401	0.0106	CbGeAlD
Celecoxib—ORM1—central nervous system—Alzheimer's disease	0.000401	0.0106	CbGeAlD
Celecoxib—Sulfaphenazole—CYP2D6—Alzheimer's disease	0.000398	0.239	CrCbGaD
Celecoxib—PTGS2—forebrain—Alzheimer's disease	0.000366	0.00968	CbGeAlD
Celecoxib—CA5B—brain—Alzheimer's disease	0.00036	0.00951	CbGeAlD
Celecoxib—ABCC4—nervous system—Alzheimer's disease	0.000353	0.00934	CbGeAlD
Celecoxib—ABCC4—central nervous system—Alzheimer's disease	0.00034	0.00899	CbGeAlD
Celecoxib—PTGS2—telencephalon—Alzheimer's disease	0.000337	0.0089	CbGeAlD
Celecoxib—CA4—nervous system—Alzheimer's disease	0.000325	0.00858	CbGeAlD
Celecoxib—CYP2D6—forebrain—Alzheimer's disease	0.000315	0.00832	CbGeAlD
Celecoxib—CA4—central nervous system—Alzheimer's disease	0.000313	0.00826	CbGeAlD
Celecoxib—CA4—cerebellum—Alzheimer's disease	0.000306	0.00808	CbGeAlD
Celecoxib—CYP2D6—telencephalon—Alzheimer's disease	0.00029	0.00765	CbGeAlD
Celecoxib—ALB—brain—Alzheimer's disease	0.000279	0.00737	CbGeAlD
Celecoxib—ABCC4—brain—Alzheimer's disease	0.00027	0.00714	CbGeAlD
Celecoxib—CA2—nervous system—Alzheimer's disease	0.000269	0.00712	CbGeAlD
Celecoxib—CA2—central nervous system—Alzheimer's disease	0.000259	0.00685	CbGeAlD
Celecoxib—CA2—cerebellum—Alzheimer's disease	0.000253	0.0067	CbGeAlD
Celecoxib—CA4—brain—Alzheimer's disease	0.000248	0.00656	CbGeAlD
Celecoxib—CA2—brain—Alzheimer's disease	0.000206	0.00544	CbGeAlD
Celecoxib—PTGS2—nervous system—Alzheimer's disease	0.000199	0.00525	CbGeAlD
Celecoxib—PTGS2—central nervous system—Alzheimer's disease	0.000191	0.00506	CbGeAlD
Celecoxib—PTGS2—cerebellum—Alzheimer's disease	0.000187	0.00494	CbGeAlD
Celecoxib—CYP3A4—nervous system—Alzheimer's disease	0.000174	0.00459	CbGeAlD
Celecoxib—CYP2D6—nervous system—Alzheimer's disease	0.000171	0.00452	CbGeAlD
Celecoxib—CYP3A4—central nervous system—Alzheimer's disease	0.000167	0.00442	CbGeAlD
Celecoxib—CYP2D6—central nervous system—Alzheimer's disease	0.000165	0.00435	CbGeAlD
Celecoxib—CYP2D6—cerebellum—Alzheimer's disease	0.000161	0.00425	CbGeAlD
Celecoxib—PTGS2—brain—Alzheimer's disease	0.000152	0.00402	CbGeAlD
Celecoxib—Arthralgia—Galantamine—Alzheimer's disease	0.000143	0.000742	CcSEcCtD
Celecoxib—Myalgia—Galantamine—Alzheimer's disease	0.000143	0.000742	CcSEcCtD
Celecoxib—Chest pain—Galantamine—Alzheimer's disease	0.000143	0.000742	CcSEcCtD
Celecoxib—Epistaxis—Memantine—Alzheimer's disease	0.000143	0.000741	CcSEcCtD
Celecoxib—Anxiety—Galantamine—Alzheimer's disease	0.000143	0.00074	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000142	0.000737	CcSEcCtD
Celecoxib—Sinusitis—Memantine—Alzheimer's disease	0.000142	0.000737	CcSEcCtD
Celecoxib—Agranulocytosis—Memantine—Alzheimer's disease	0.000141	0.000733	CcSEcCtD
Celecoxib—Haematuria—Rivastigmine—Alzheimer's disease	0.000141	0.000732	CcSEcCtD
Celecoxib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00014	0.000726	CcSEcCtD
Celecoxib—Dry mouth—Galantamine—Alzheimer's disease	0.00014	0.000726	CcSEcCtD
Celecoxib—Epistaxis—Rivastigmine—Alzheimer's disease	0.00014	0.000724	CcSEcCtD
Celecoxib—Tinnitus—Donepezil—Alzheimer's disease	0.00014	0.000724	CcSEcCtD
Celecoxib—Sinusitis—Rivastigmine—Alzheimer's disease	0.000139	0.000721	CcSEcCtD
Celecoxib—Confusional state—Galantamine—Alzheimer's disease	0.000139	0.000718	CcSEcCtD
Celecoxib—Haemoglobin—Memantine—Alzheimer's disease	0.000137	0.000708	CcSEcCtD
Celecoxib—Rhinitis—Memantine—Alzheimer's disease	0.000136	0.000707	CcSEcCtD
Celecoxib—Haemorrhage—Memantine—Alzheimer's disease	0.000136	0.000705	CcSEcCtD
Celecoxib—Hepatitis—Memantine—Alzheimer's disease	0.000136	0.000705	CcSEcCtD
Celecoxib—Hallucination—Memantine—Alzheimer's disease	0.000135	0.000701	CcSEcCtD
Celecoxib—Hypoaesthesia—Memantine—Alzheimer's disease	0.000135	0.000701	CcSEcCtD
Celecoxib—Shock—Galantamine—Alzheimer's disease	0.000135	0.0007	CcSEcCtD
Celecoxib—Pharyngitis—Memantine—Alzheimer's disease	0.000135	0.0007	CcSEcCtD
Celecoxib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000135	0.000698	CcSEcCtD
Celecoxib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000135	0.000697	CcSEcCtD
Celecoxib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000134	0.000696	CcSEcCtD
Celecoxib—Tachycardia—Galantamine—Alzheimer's disease	0.000134	0.000694	CcSEcCtD
Celecoxib—Oedema peripheral—Memantine—Alzheimer's disease	0.000134	0.000694	CcSEcCtD
Celecoxib—Arrhythmia—Donepezil—Alzheimer's disease	0.000134	0.000693	CcSEcCtD
Celecoxib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000134	0.000693	CcSEcCtD
Celecoxib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000134	0.000693	CcSEcCtD
Celecoxib—Rhinitis—Rivastigmine—Alzheimer's disease	0.000133	0.000691	CcSEcCtD
Celecoxib—Skin disorder—Galantamine—Alzheimer's disease	0.000133	0.000691	CcSEcCtD
Celecoxib—Urethral disorder—Memantine—Alzheimer's disease	0.000133	0.000691	CcSEcCtD
Celecoxib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000133	0.000689	CcSEcCtD
Celecoxib—Hepatitis—Rivastigmine—Alzheimer's disease	0.000133	0.000689	CcSEcCtD
Celecoxib—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000133	0.000688	CcSEcCtD
Celecoxib—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000132	0.000686	CcSEcCtD
Celecoxib—Hallucination—Rivastigmine—Alzheimer's disease	0.000132	0.000686	CcSEcCtD
Celecoxib—Alopecia—Donepezil—Alzheimer's disease	0.000132	0.000686	CcSEcCtD
Celecoxib—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000132	0.000684	CcSEcCtD
Celecoxib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000131	0.000681	CcSEcCtD
Celecoxib—Mental disorder—Donepezil—Alzheimer's disease	0.000131	0.00068	CcSEcCtD
Celecoxib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000131	0.000679	CcSEcCtD
Celecoxib—Anorexia—Galantamine—Alzheimer's disease	0.000131	0.000678	CcSEcCtD
Celecoxib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000131	0.000678	CcSEcCtD
Celecoxib—CYP2D6—brain—Alzheimer's disease	0.000131	0.00345	CbGeAlD
Celecoxib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000131	0.000676	CcSEcCtD
Celecoxib—Erythema multiforme—Memantine—Alzheimer's disease	0.000129	0.000666	CcSEcCtD
Celecoxib—Flatulence—Donepezil—Alzheimer's disease	0.000129	0.000666	CcSEcCtD
Celecoxib—Tension—Donepezil—Alzheimer's disease	0.000128	0.000663	CcSEcCtD
Celecoxib—Dysgeusia—Donepezil—Alzheimer's disease	0.000128	0.000662	CcSEcCtD
Celecoxib—Eye disorder—Memantine—Alzheimer's disease	0.000127	0.000659	CcSEcCtD
Celecoxib—Tinnitus—Memantine—Alzheimer's disease	0.000127	0.000657	CcSEcCtD
Celecoxib—Nervousness—Donepezil—Alzheimer's disease	0.000127	0.000656	CcSEcCtD
Celecoxib—Flushing—Memantine—Alzheimer's disease	0.000126	0.000654	CcSEcCtD
Celecoxib—Cardiac disorder—Memantine—Alzheimer's disease	0.000126	0.000654	CcSEcCtD
Celecoxib—Back pain—Donepezil—Alzheimer's disease	0.000126	0.000654	CcSEcCtD
Celecoxib—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000126	0.000652	CcSEcCtD
Celecoxib—Muscle spasms—Donepezil—Alzheimer's disease	0.000125	0.00065	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000125	0.000648	CcSEcCtD
Celecoxib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000124	0.000644	CcSEcCtD
Celecoxib—Insomnia—Galantamine—Alzheimer's disease	0.000124	0.000644	CcSEcCtD
Celecoxib—Tinnitus—Rivastigmine—Alzheimer's disease	0.000124	0.000643	CcSEcCtD
Celecoxib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000124	0.00064	CcSEcCtD
Celecoxib—Flushing—Rivastigmine—Alzheimer's disease	0.000124	0.00064	CcSEcCtD
Celecoxib—Angiopathy—Memantine—Alzheimer's disease	0.000123	0.000639	CcSEcCtD
Celecoxib—Paraesthesia—Galantamine—Alzheimer's disease	0.000123	0.000639	CcSEcCtD
Celecoxib—Vision blurred—Donepezil—Alzheimer's disease	0.000123	0.000637	CcSEcCtD
Celecoxib—Immune system disorder—Memantine—Alzheimer's disease	0.000123	0.000637	CcSEcCtD
Celecoxib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000123	0.000635	CcSEcCtD
Celecoxib—Somnolence—Galantamine—Alzheimer's disease	0.000122	0.000633	CcSEcCtD
Celecoxib—Arrhythmia—Memantine—Alzheimer's disease	0.000122	0.00063	CcSEcCtD
Celecoxib—Dyspepsia—Galantamine—Alzheimer's disease	0.000121	0.000626	CcSEcCtD
Celecoxib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000121	0.000626	CcSEcCtD
Celecoxib—Anaemia—Donepezil—Alzheimer's disease	0.000121	0.000625	CcSEcCtD
Celecoxib—Alopecia—Memantine—Alzheimer's disease	0.00012	0.000623	CcSEcCtD
Celecoxib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00012	0.000621	CcSEcCtD
Celecoxib—Decreased appetite—Galantamine—Alzheimer's disease	0.000119	0.000619	CcSEcCtD
Celecoxib—Mental disorder—Memantine—Alzheimer's disease	0.000119	0.000617	CcSEcCtD
Celecoxib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000119	0.000616	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000119	0.000614	CcSEcCtD
Celecoxib—Fatigue—Galantamine—Alzheimer's disease	0.000118	0.000614	CcSEcCtD
Celecoxib—Alopecia—Rivastigmine—Alzheimer's disease	0.000118	0.000609	CcSEcCtD
Celecoxib—Constipation—Galantamine—Alzheimer's disease	0.000118	0.000609	CcSEcCtD
Celecoxib—Vertigo—Donepezil—Alzheimer's disease	0.000117	0.000607	CcSEcCtD
Celecoxib—Syncope—Donepezil—Alzheimer's disease	0.000117	0.000606	CcSEcCtD
Celecoxib—Flatulence—Memantine—Alzheimer's disease	0.000117	0.000605	CcSEcCtD
Celecoxib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000117	0.000604	CcSEcCtD
Celecoxib—Tension—Memantine—Alzheimer's disease	0.000116	0.000602	CcSEcCtD
Celecoxib—Dysgeusia—Memantine—Alzheimer's disease	0.000116	0.000601	CcSEcCtD
Celecoxib—Nervousness—Memantine—Alzheimer's disease	0.000115	0.000596	CcSEcCtD
Celecoxib—Loss of consciousness—Donepezil—Alzheimer's disease	0.000115	0.000594	CcSEcCtD
Celecoxib—Back pain—Memantine—Alzheimer's disease	0.000115	0.000593	CcSEcCtD
Celecoxib—Flatulence—Rivastigmine—Alzheimer's disease	0.000114	0.000591	CcSEcCtD
Celecoxib—Cough—Donepezil—Alzheimer's disease	0.000114	0.00059	CcSEcCtD
Celecoxib—Tension—Rivastigmine—Alzheimer's disease	0.000114	0.000589	CcSEcCtD
Celecoxib—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000114	0.000588	CcSEcCtD
Celecoxib—Feeling abnormal—Galantamine—Alzheimer's disease	0.000113	0.000586	CcSEcCtD
Celecoxib—Hypertension—Donepezil—Alzheimer's disease	0.000113	0.000583	CcSEcCtD
Celecoxib—Nervousness—Rivastigmine—Alzheimer's disease	0.000113	0.000583	CcSEcCtD
Celecoxib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000112	0.000582	CcSEcCtD
Celecoxib—Back pain—Rivastigmine—Alzheimer's disease	0.000112	0.000581	CcSEcCtD
Celecoxib—Vision blurred—Memantine—Alzheimer's disease	0.000112	0.000578	CcSEcCtD
Celecoxib—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000111	0.000577	CcSEcCtD
Celecoxib—Myalgia—Donepezil—Alzheimer's disease	0.000111	0.000575	CcSEcCtD
Celecoxib—Chest pain—Donepezil—Alzheimer's disease	0.000111	0.000575	CcSEcCtD
Celecoxib—Arthralgia—Donepezil—Alzheimer's disease	0.000111	0.000575	CcSEcCtD
Celecoxib—Anxiety—Donepezil—Alzheimer's disease	0.000111	0.000573	CcSEcCtD
Celecoxib—Anaemia—Memantine—Alzheimer's disease	0.00011	0.000567	CcSEcCtD
Celecoxib—Vision blurred—Rivastigmine—Alzheimer's disease	0.000109	0.000566	CcSEcCtD
Celecoxib—Dry mouth—Donepezil—Alzheimer's disease	0.000109	0.000563	CcSEcCtD
Celecoxib—Abdominal pain—Galantamine—Alzheimer's disease	0.000109	0.000563	CcSEcCtD
Celecoxib—Body temperature increased—Galantamine—Alzheimer's disease	0.000109	0.000563	CcSEcCtD
Celecoxib—Confusional state—Donepezil—Alzheimer's disease	0.000107	0.000556	CcSEcCtD
Celecoxib—Anaemia—Rivastigmine—Alzheimer's disease	0.000107	0.000555	CcSEcCtD
Celecoxib—Oedema—Donepezil—Alzheimer's disease	0.000106	0.000551	CcSEcCtD
Celecoxib—Vertigo—Memantine—Alzheimer's disease	0.000106	0.000551	CcSEcCtD
Celecoxib—Syncope—Memantine—Alzheimer's disease	0.000106	0.00055	CcSEcCtD
Celecoxib—Leukopenia—Memantine—Alzheimer's disease	0.000106	0.000549	CcSEcCtD
Celecoxib—Infection—Donepezil—Alzheimer's disease	0.000106	0.000548	CcSEcCtD
Celecoxib—Shock—Donepezil—Alzheimer's disease	0.000105	0.000543	CcSEcCtD
Celecoxib—Palpitations—Memantine—Alzheimer's disease	0.000105	0.000542	CcSEcCtD
Celecoxib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000104	0.000541	CcSEcCtD
Celecoxib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000104	0.00054	CcSEcCtD
Celecoxib—Vertigo—Rivastigmine—Alzheimer's disease	0.000104	0.000539	CcSEcCtD
Celecoxib—Loss of consciousness—Memantine—Alzheimer's disease	0.000104	0.000539	CcSEcCtD
Celecoxib—Syncope—Rivastigmine—Alzheimer's disease	0.000104	0.000538	CcSEcCtD
Celecoxib—Cough—Memantine—Alzheimer's disease	0.000103	0.000535	CcSEcCtD
Celecoxib—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000103	0.000533	CcSEcCtD
Celecoxib—Palpitations—Rivastigmine—Alzheimer's disease	0.000102	0.00053	CcSEcCtD
Celecoxib—Hypertension—Memantine—Alzheimer's disease	0.000102	0.00053	CcSEcCtD
Celecoxib—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000102	0.000528	CcSEcCtD
Celecoxib—Anorexia—Donepezil—Alzheimer's disease	0.000102	0.000526	CcSEcCtD
Celecoxib—Hypersensitivity—Galantamine—Alzheimer's disease	0.000101	0.000524	CcSEcCtD
Celecoxib—Cough—Rivastigmine—Alzheimer's disease	0.000101	0.000524	CcSEcCtD
Celecoxib—Myalgia—Memantine—Alzheimer's disease	0.000101	0.000522	CcSEcCtD
Celecoxib—Chest pain—Memantine—Alzheimer's disease	0.000101	0.000522	CcSEcCtD
Celecoxib—Arthralgia—Memantine—Alzheimer's disease	0.000101	0.000522	CcSEcCtD
Celecoxib—Anxiety—Memantine—Alzheimer's disease	0.000101	0.000521	CcSEcCtD
Celecoxib—Hypertension—Rivastigmine—Alzheimer's disease	0.0001	0.000518	CcSEcCtD
Celecoxib—Arthralgia—Rivastigmine—Alzheimer's disease	9.87e-05	0.000511	CcSEcCtD
Celecoxib—Chest pain—Rivastigmine—Alzheimer's disease	9.87e-05	0.000511	CcSEcCtD
Celecoxib—Myalgia—Rivastigmine—Alzheimer's disease	9.87e-05	0.000511	CcSEcCtD
Celecoxib—Dry mouth—Memantine—Alzheimer's disease	9.87e-05	0.000511	CcSEcCtD
Celecoxib—Asthenia—Galantamine—Alzheimer's disease	9.86e-05	0.000511	CcSEcCtD
Celecoxib—Anxiety—Rivastigmine—Alzheimer's disease	9.83e-05	0.000509	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	9.8e-05	0.000507	CcSEcCtD
Celecoxib—Confusional state—Memantine—Alzheimer's disease	9.75e-05	0.000505	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	9.7e-05	0.000502	CcSEcCtD
Celecoxib—Oedema—Memantine—Alzheimer's disease	9.67e-05	0.000501	CcSEcCtD
Celecoxib—Dry mouth—Rivastigmine—Alzheimer's disease	9.65e-05	0.0005	CcSEcCtD
Celecoxib—Insomnia—Donepezil—Alzheimer's disease	9.63e-05	0.000499	CcSEcCtD
Celecoxib—Infection—Memantine—Alzheimer's disease	9.61e-05	0.000497	CcSEcCtD
Celecoxib—Paraesthesia—Donepezil—Alzheimer's disease	9.56e-05	0.000495	CcSEcCtD
Celecoxib—Confusional state—Rivastigmine—Alzheimer's disease	9.54e-05	0.000494	CcSEcCtD
Celecoxib—Shock—Memantine—Alzheimer's disease	9.51e-05	0.000493	CcSEcCtD
Celecoxib—Dyspnoea—Donepezil—Alzheimer's disease	9.49e-05	0.000492	CcSEcCtD
Celecoxib—Nervous system disorder—Memantine—Alzheimer's disease	9.48e-05	0.000491	CcSEcCtD
Celecoxib—Somnolence—Donepezil—Alzheimer's disease	9.47e-05	0.00049	CcSEcCtD
Celecoxib—Thrombocytopenia—Memantine—Alzheimer's disease	9.47e-05	0.00049	CcSEcCtD
Celecoxib—Oedema—Rivastigmine—Alzheimer's disease	9.46e-05	0.00049	CcSEcCtD
Celecoxib—Tachycardia—Memantine—Alzheimer's disease	9.44e-05	0.000489	CcSEcCtD
Celecoxib—Diarrhoea—Galantamine—Alzheimer's disease	9.4e-05	0.000487	CcSEcCtD
Celecoxib—Infection—Rivastigmine—Alzheimer's disease	9.4e-05	0.000487	CcSEcCtD
Celecoxib—Skin disorder—Memantine—Alzheimer's disease	9.39e-05	0.000486	CcSEcCtD
Celecoxib—Dyspepsia—Donepezil—Alzheimer's disease	9.37e-05	0.000485	CcSEcCtD
Celecoxib—Hyperhidrosis—Memantine—Alzheimer's disease	9.35e-05	0.000484	CcSEcCtD
Celecoxib—Shock—Rivastigmine—Alzheimer's disease	9.31e-05	0.000482	CcSEcCtD
Celecoxib—Nervous system disorder—Rivastigmine—Alzheimer's disease	9.28e-05	0.00048	CcSEcCtD
Celecoxib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	9.26e-05	0.00048	CcSEcCtD
Celecoxib—Decreased appetite—Donepezil—Alzheimer's disease	9.26e-05	0.000479	CcSEcCtD
Celecoxib—Tachycardia—Rivastigmine—Alzheimer's disease	9.23e-05	0.000478	CcSEcCtD
Celecoxib—Anorexia—Memantine—Alzheimer's disease	9.22e-05	0.000477	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	9.19e-05	0.000476	CcSEcCtD
Celecoxib—Skin disorder—Rivastigmine—Alzheimer's disease	9.19e-05	0.000476	CcSEcCtD
Celecoxib—Fatigue—Donepezil—Alzheimer's disease	9.18e-05	0.000475	CcSEcCtD
Celecoxib—Hyperhidrosis—Rivastigmine—Alzheimer's disease	9.14e-05	0.000474	CcSEcCtD
Celecoxib—Constipation—Donepezil—Alzheimer's disease	9.11e-05	0.000472	CcSEcCtD
Celecoxib—Dizziness—Galantamine—Alzheimer's disease	9.09e-05	0.000471	CcSEcCtD
Celecoxib—Anorexia—Rivastigmine—Alzheimer's disease	9.02e-05	0.000467	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	8.81e-05	0.000456	CcSEcCtD
Celecoxib—Feeling abnormal—Donepezil—Alzheimer's disease	8.78e-05	0.000454	CcSEcCtD
Celecoxib—Insomnia—Memantine—Alzheimer's disease	8.75e-05	0.000453	CcSEcCtD
Celecoxib—Vomiting—Galantamine—Alzheimer's disease	8.74e-05	0.000452	CcSEcCtD
Celecoxib—Gastrointestinal pain—Donepezil—Alzheimer's disease	8.71e-05	0.000451	CcSEcCtD
Celecoxib—Paraesthesia—Memantine—Alzheimer's disease	8.68e-05	0.00045	CcSEcCtD
Celecoxib—Rash—Galantamine—Alzheimer's disease	8.66e-05	0.000449	CcSEcCtD
Celecoxib—Dermatitis—Galantamine—Alzheimer's disease	8.66e-05	0.000448	CcSEcCtD
Celecoxib—Dyspnoea—Memantine—Alzheimer's disease	8.62e-05	0.000446	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	8.62e-05	0.000446	CcSEcCtD
Celecoxib—Headache—Galantamine—Alzheimer's disease	8.61e-05	0.000446	CcSEcCtD
Celecoxib—Somnolence—Memantine—Alzheimer's disease	8.6e-05	0.000445	CcSEcCtD
Celecoxib—Insomnia—Rivastigmine—Alzheimer's disease	8.56e-05	0.000443	CcSEcCtD
Celecoxib—Dyspepsia—Memantine—Alzheimer's disease	8.51e-05	0.000441	CcSEcCtD
Celecoxib—Paraesthesia—Rivastigmine—Alzheimer's disease	8.49e-05	0.00044	CcSEcCtD
Celecoxib—Urticaria—Donepezil—Alzheimer's disease	8.46e-05	0.000438	CcSEcCtD
Celecoxib—Dyspnoea—Rivastigmine—Alzheimer's disease	8.43e-05	0.000437	CcSEcCtD
Celecoxib—Abdominal pain—Donepezil—Alzheimer's disease	8.42e-05	0.000436	CcSEcCtD
Celecoxib—Body temperature increased—Donepezil—Alzheimer's disease	8.42e-05	0.000436	CcSEcCtD
Celecoxib—Somnolence—Rivastigmine—Alzheimer's disease	8.41e-05	0.000435	CcSEcCtD
Celecoxib—Decreased appetite—Memantine—Alzheimer's disease	8.41e-05	0.000435	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Memantine—Alzheimer's disease	8.35e-05	0.000432	CcSEcCtD
Celecoxib—Fatigue—Memantine—Alzheimer's disease	8.34e-05	0.000432	CcSEcCtD
Celecoxib—Dyspepsia—Rivastigmine—Alzheimer's disease	8.33e-05	0.000431	CcSEcCtD
Celecoxib—Constipation—Memantine—Alzheimer's disease	8.27e-05	0.000428	CcSEcCtD
Celecoxib—Decreased appetite—Rivastigmine—Alzheimer's disease	8.22e-05	0.000426	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	8.17e-05	0.000423	CcSEcCtD
Celecoxib—Nausea—Galantamine—Alzheimer's disease	8.16e-05	0.000423	CcSEcCtD
Celecoxib—Fatigue—Rivastigmine—Alzheimer's disease	8.16e-05	0.000422	CcSEcCtD
Celecoxib—Constipation—Rivastigmine—Alzheimer's disease	8.09e-05	0.000419	CcSEcCtD
Celecoxib—Feeling abnormal—Memantine—Alzheimer's disease	7.97e-05	0.000413	CcSEcCtD
Celecoxib—Gastrointestinal pain—Memantine—Alzheimer's disease	7.91e-05	0.000409	CcSEcCtD
Celecoxib—Hypersensitivity—Donepezil—Alzheimer's disease	7.85e-05	0.000406	CcSEcCtD
Celecoxib—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.8e-05	0.000404	CcSEcCtD
Celecoxib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	7.74e-05	0.000401	CcSEcCtD
Celecoxib—Urticaria—Memantine—Alzheimer's disease	7.68e-05	0.000398	CcSEcCtD
Celecoxib—Body temperature increased—Memantine—Alzheimer's disease	7.64e-05	0.000396	CcSEcCtD
Celecoxib—Abdominal pain—Memantine—Alzheimer's disease	7.64e-05	0.000396	CcSEcCtD
Celecoxib—Asthenia—Donepezil—Alzheimer's disease	7.64e-05	0.000396	CcSEcCtD
Celecoxib—Pruritus—Donepezil—Alzheimer's disease	7.53e-05	0.00039	CcSEcCtD
Celecoxib—Urticaria—Rivastigmine—Alzheimer's disease	7.52e-05	0.000389	CcSEcCtD
Celecoxib—Abdominal pain—Rivastigmine—Alzheimer's disease	7.48e-05	0.000387	CcSEcCtD
Celecoxib—Body temperature increased—Rivastigmine—Alzheimer's disease	7.48e-05	0.000387	CcSEcCtD
Celecoxib—Diarrhoea—Donepezil—Alzheimer's disease	7.29e-05	0.000377	CcSEcCtD
Celecoxib—Hypersensitivity—Memantine—Alzheimer's disease	7.12e-05	0.000369	CcSEcCtD
Celecoxib—Dizziness—Donepezil—Alzheimer's disease	7.04e-05	0.000365	CcSEcCtD
Celecoxib—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.97e-05	0.000361	CcSEcCtD
Celecoxib—Asthenia—Memantine—Alzheimer's disease	6.94e-05	0.000359	CcSEcCtD
Celecoxib—Pruritus—Memantine—Alzheimer's disease	6.84e-05	0.000354	CcSEcCtD
Celecoxib—Asthenia—Rivastigmine—Alzheimer's disease	6.79e-05	0.000351	CcSEcCtD
Celecoxib—Vomiting—Donepezil—Alzheimer's disease	6.77e-05	0.000351	CcSEcCtD
Celecoxib—Rash—Donepezil—Alzheimer's disease	6.71e-05	0.000348	CcSEcCtD
Celecoxib—Dermatitis—Donepezil—Alzheimer's disease	6.71e-05	0.000347	CcSEcCtD
Celecoxib—Pruritus—Rivastigmine—Alzheimer's disease	6.69e-05	0.000347	CcSEcCtD
Celecoxib—Headache—Donepezil—Alzheimer's disease	6.67e-05	0.000345	CcSEcCtD
Celecoxib—Diarrhoea—Memantine—Alzheimer's disease	6.62e-05	0.000343	CcSEcCtD
Celecoxib—Diarrhoea—Rivastigmine—Alzheimer's disease	6.47e-05	0.000335	CcSEcCtD
Celecoxib—Dizziness—Memantine—Alzheimer's disease	6.39e-05	0.000331	CcSEcCtD
Celecoxib—Nausea—Donepezil—Alzheimer's disease	6.33e-05	0.000328	CcSEcCtD
Celecoxib—Dizziness—Rivastigmine—Alzheimer's disease	6.26e-05	0.000324	CcSEcCtD
Celecoxib—Vomiting—Memantine—Alzheimer's disease	6.15e-05	0.000318	CcSEcCtD
Celecoxib—Rash—Memantine—Alzheimer's disease	6.1e-05	0.000316	CcSEcCtD
Celecoxib—Dermatitis—Memantine—Alzheimer's disease	6.09e-05	0.000315	CcSEcCtD
Celecoxib—Headache—Memantine—Alzheimer's disease	6.06e-05	0.000314	CcSEcCtD
Celecoxib—Vomiting—Rivastigmine—Alzheimer's disease	6.01e-05	0.000311	CcSEcCtD
Celecoxib—Rash—Rivastigmine—Alzheimer's disease	5.96e-05	0.000309	CcSEcCtD
Celecoxib—Dermatitis—Rivastigmine—Alzheimer's disease	5.96e-05	0.000309	CcSEcCtD
Celecoxib—Headache—Rivastigmine—Alzheimer's disease	5.93e-05	0.000307	CcSEcCtD
Celecoxib—Nausea—Memantine—Alzheimer's disease	5.74e-05	0.000297	CcSEcCtD
Celecoxib—Nausea—Rivastigmine—Alzheimer's disease	5.62e-05	0.000291	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—PLCB1—Alzheimer's disease	5.41e-06	4.5e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GAB2—Alzheimer's disease	5.36e-06	4.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAPK8—Alzheimer's disease	5.35e-06	4.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CALM1—Alzheimer's disease	5.35e-06	4.45e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PLAU—Alzheimer's disease	5.33e-06	4.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GSK3A—Alzheimer's disease	5.32e-06	4.43e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CALM1—Alzheimer's disease	5.27e-06	4.39e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TPI1—Alzheimer's disease	5.24e-06	4.37e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CHAT—Alzheimer's disease	5.24e-06	4.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APP—Alzheimer's disease	5.23e-06	4.35e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CAV1—Alzheimer's disease	5.21e-06	4.34e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	5.17e-06	4.3e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.15e-06	4.29e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—Alzheimer's disease	5.13e-06	4.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.13e-06	4.27e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NOS3—Alzheimer's disease	5.12e-06	4.26e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—ESR1—Alzheimer's disease	5.06e-06	4.21e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	5.05e-06	4.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGFR—Alzheimer's disease	5.04e-06	4.2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—Alzheimer's disease	5.04e-06	4.19e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MAOB—Alzheimer's disease	5.03e-06	4.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ACHE—Alzheimer's disease	5.03e-06	4.18e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—Alzheimer's disease	4.97e-06	4.14e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INPP5D—Alzheimer's disease	4.97e-06	4.14e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—F2—Alzheimer's disease	4.96e-06	4.13e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.93e-06	4.1e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADAM10—Alzheimer's disease	4.93e-06	4.1e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—Alzheimer's disease	4.9e-06	4.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NOTCH1—Alzheimer's disease	4.89e-06	4.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.88e-06	4.06e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GAPDH—Alzheimer's disease	4.84e-06	4.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—Alzheimer's disease	4.79e-06	3.99e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.78e-06	3.98e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.74e-06	3.95e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—Alzheimer's disease	4.74e-06	3.94e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.72e-06	3.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ENO1—Alzheimer's disease	4.71e-06	3.92e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTGS1—Alzheimer's disease	4.71e-06	3.92e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—Alzheimer's disease	4.69e-06	3.91e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—Alzheimer's disease	4.68e-06	3.9e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—A2M—Alzheimer's disease	4.67e-06	3.89e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.67e-06	3.89e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—S100B—Alzheimer's disease	4.66e-06	3.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	4.62e-06	3.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARG—Alzheimer's disease	4.62e-06	3.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—GSK3B—Alzheimer's disease	4.62e-06	3.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CREB1—Alzheimer's disease	4.58e-06	3.81e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	4.55e-06	3.79e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ADAM10—Alzheimer's disease	4.5e-06	3.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF2—Alzheimer's disease	4.44e-06	3.69e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ND1—Alzheimer's disease	4.39e-06	3.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—BCHE—Alzheimer's disease	4.38e-06	3.65e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF1—Alzheimer's disease	4.34e-06	3.62e-05	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AKT1—Alzheimer's disease	4.33e-06	3.61e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TPI1—Alzheimer's disease	4.33e-06	3.6e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CHAT—Alzheimer's disease	4.33e-06	3.6e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CHAT—Alzheimer's disease	4.29e-06	3.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TPI1—Alzheimer's disease	4.29e-06	3.57e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1R—Alzheimer's disease	4.29e-06	3.57e-05	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.26e-06	3.55e-05	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AKT1—Alzheimer's disease	4.22e-06	3.52e-05	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AKT1—Alzheimer's disease	4.22e-06	3.52e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CASP3—Alzheimer's disease	4.22e-06	3.51e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—Alzheimer's disease	4.19e-06	3.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.17e-06	3.47e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MAOB—Alzheimer's disease	4.15e-06	3.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—Alzheimer's disease	4.15e-06	3.45e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLCB1—Alzheimer's disease	4.13e-06	3.44e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MAOB—Alzheimer's disease	4.11e-06	3.43e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LPL—Alzheimer's disease	4.11e-06	3.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MEF2C—Alzheimer's disease	4.08e-06	3.39e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ACHE—Alzheimer's disease	4.07e-06	3.39e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INPP5D—Alzheimer's disease	4.02e-06	3.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCA1—Alzheimer's disease	4e-06	3.33e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—AKT1—Alzheimer's disease	4e-06	3.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCG—Alzheimer's disease	4e-06	3.33e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	4e-06	3.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	3.96e-06	3.3e-05	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AKT1—Alzheimer's disease	3.94e-06	3.28e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—Alzheimer's disease	3.94e-06	3.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.92e-06	3.26e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGF—Alzheimer's disease	3.9e-06	3.24e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.88e-06	3.23e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK8—Alzheimer's disease	3.88e-06	3.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—Alzheimer's disease	3.87e-06	3.22e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AKT1—Alzheimer's disease	3.87e-06	3.22e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—A2M—Alzheimer's disease	3.86e-06	3.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BCL2—Alzheimer's disease	3.85e-06	3.2e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—Alzheimer's disease	3.83e-06	3.19e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—A2M—Alzheimer's disease	3.83e-06	3.19e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO1—Alzheimer's disease	3.81e-06	3.17e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS1—Alzheimer's disease	3.81e-06	3.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR5—Alzheimer's disease	3.79e-06	3.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—LPL—Alzheimer's disease	3.75e-06	3.12e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2D6—Alzheimer's disease	3.74e-06	3.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2A—Alzheimer's disease	3.71e-06	3.09e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AKT1—Alzheimer's disease	3.65e-06	3.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRKCG—Alzheimer's disease	3.65e-06	3.04e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—Alzheimer's disease	3.58e-06	2.98e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—AKT1—Alzheimer's disease	3.57e-06	2.97e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—BCHE—Alzheimer's disease	3.54e-06	2.95e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—Alzheimer's disease	3.54e-06	2.94e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—AKT1—Alzheimer's disease	3.53e-06	2.94e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	3.51e-06	2.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—AKT1—Alzheimer's disease	3.5e-06	2.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALM1—Alzheimer's disease	3.46e-06	2.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CCR5—Alzheimer's disease	3.46e-06	2.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	3.45e-06	2.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—Alzheimer's disease	3.45e-06	2.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—Alzheimer's disease	3.45e-06	2.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HMOX1—Alzheimer's disease	3.44e-06	2.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—Alzheimer's disease	3.42e-06	2.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CAV1—Alzheimer's disease	3.42e-06	2.84e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.41e-06	2.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—Alzheimer's disease	3.4e-06	2.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—Alzheimer's disease	3.38e-06	2.81e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ACHE—Alzheimer's disease	3.36e-06	2.79e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLCB1—Alzheimer's disease	3.34e-06	2.78e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ACHE—Alzheimer's disease	3.33e-06	2.77e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	3.32e-06	2.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ESR1—Alzheimer's disease	3.29e-06	2.74e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	3.29e-06	2.74e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—Alzheimer's disease	3.29e-06	2.74e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.28e-06	2.73e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—Alzheimer's disease	3.26e-06	2.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—F2—Alzheimer's disease	3.25e-06	2.71e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCA1—Alzheimer's disease	3.24e-06	2.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOTCH1—Alzheimer's disease	3.18e-06	2.65e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALM1—Alzheimer's disease	3.16e-06	2.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—Alzheimer's disease	3.15e-06	2.62e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO1—Alzheimer's disease	3.15e-06	2.62e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	3.15e-06	2.62e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—Alzheimer's disease	3.14e-06	2.62e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LPL—Alzheimer's disease	3.14e-06	2.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.12e-06	2.6e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.12e-06	2.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK8—Alzheimer's disease	3.12e-06	2.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CAV1—Alzheimer's disease	3.12e-06	2.59e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	3.06e-06	2.55e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GSK3B—Alzheimer's disease	2.99e-06	2.49e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CREB1—Alzheimer's disease	2.96e-06	2.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INS—Alzheimer's disease	2.94e-06	2.45e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—Alzheimer's disease	2.93e-06	2.44e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—BCHE—Alzheimer's disease	2.92e-06	2.43e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—Alzheimer's disease	2.91e-06	2.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOTCH1—Alzheimer's disease	2.9e-06	2.42e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.9e-06	2.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—Alzheimer's disease	2.9e-06	2.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—Alzheimer's disease	2.85e-06	2.37e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—Alzheimer's disease	2.84e-06	2.36e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.83e-06	2.36e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.83e-06	2.36e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—Alzheimer's disease	2.83e-06	2.36e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARGC1A—Alzheimer's disease	2.79e-06	2.32e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—Alzheimer's disease	2.79e-06	2.32e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—Alzheimer's disease	2.78e-06	2.31e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.76e-06	2.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.74e-06	2.28e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GSK3B—Alzheimer's disease	2.72e-06	2.27e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.71e-06	2.26e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—Alzheimer's disease	2.71e-06	2.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CREB1—Alzheimer's disease	2.7e-06	2.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—INS—Alzheimer's disease	2.69e-06	2.24e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.68e-06	2.23e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.67e-06	2.23e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.65e-06	2.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CALM1—Alzheimer's disease	2.64e-06	2.2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—Alzheimer's disease	2.63e-06	2.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.61e-06	2.17e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAV1—Alzheimer's disease	2.61e-06	2.17e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—Alzheimer's disease	2.6e-06	2.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—Alzheimer's disease	2.58e-06	2.15e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LPL—Alzheimer's disease	2.54e-06	2.12e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.52e-06	2.1e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—Alzheimer's disease	2.48e-06	2.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—Alzheimer's disease	2.36e-06	1.96e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—Alzheimer's disease	2.35e-06	1.96e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.31e-06	1.92e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.29e-06	1.91e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—Alzheimer's disease	2.29e-06	1.91e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—Alzheimer's disease	2.29e-06	1.91e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.29e-06	1.9e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—Alzheimer's disease	2.28e-06	1.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.27e-06	1.89e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INS—Alzheimer's disease	2.25e-06	1.87e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.19e-06	1.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—Alzheimer's disease	2.19e-06	1.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.17e-06	1.81e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—Alzheimer's disease	2.14e-06	1.78e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CALM1—Alzheimer's disease	2.14e-06	1.78e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—Alzheimer's disease	2.13e-06	1.77e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAV1—Alzheimer's disease	2.11e-06	1.76e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.1e-06	1.75e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.08e-06	1.73e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.06e-06	1.71e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.06e-06	1.71e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.02e-06	1.68e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK8—Alzheimer's disease	2.02e-06	1.68e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—Alzheimer's disease	1.99e-06	1.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—Alzheimer's disease	1.97e-06	1.64e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.91e-06	1.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.89e-06	1.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.87e-06	1.56e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-06	1.55e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—Alzheimer's disease	1.86e-06	1.55e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—Alzheimer's disease	1.84e-06	1.53e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—Alzheimer's disease	1.83e-06	1.52e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INS—Alzheimer's disease	1.82e-06	1.52e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—Alzheimer's disease	1.81e-06	1.51e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.8e-06	1.5e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.77e-06	1.47e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.76e-06	1.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.75e-06	1.46e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.75e-06	1.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.74e-06	1.45e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.74e-06	1.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.73e-06	1.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—Alzheimer's disease	1.71e-06	1.42e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—Alzheimer's disease	1.6e-06	1.33e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—Alzheimer's disease	1.56e-06	1.3e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.53e-06	1.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.52e-06	1.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.51e-06	1.25e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INS—Alzheimer's disease	1.5e-06	1.25e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.5e-06	1.25e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INS—Alzheimer's disease	1.49e-06	1.24e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—Alzheimer's disease	1.46e-06	1.22e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—Alzheimer's disease	1.41e-06	1.17e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.37e-06	1.14e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.32e-06	1.1e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.31e-06	1.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—Alzheimer's disease	1.29e-06	1.07e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.24e-06	1.03e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.21e-06	1e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.2e-06	9.95e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—Alzheimer's disease	1.19e-06	9.88e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—Alzheimer's disease	1.17e-06	9.77e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.15e-06	9.61e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.15e-06	9.58e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.14e-06	9.49e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—Alzheimer's disease	1.08e-06	9.02e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1e-06	8.34e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INS—Alzheimer's disease	9.83e-07	8.18e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—Alzheimer's disease	9.07e-07	7.55e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	8.62e-07	7.17e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.88e-07	6.56e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—Alzheimer's disease	7.34e-07	6.11e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.06e-07	5.04e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—Alzheimer's disease	6.01e-07	5e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.96e-07	3.3e-06	CbGpPWpGaD
